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The Annual Meeting of the Associazione Italiana di Colture
Cellulari (ONLUS-AICC) in collaboration with Phoenix Stem
Cell Foundation for Human Life (Phoenix-ONLUS) was held
during 2–4 December 2009, in Florence (Italy).
AICC has been known for more than 20 years for its
promoting initiatives regarding cell cultures. The Phoenix
Foundation was born in March 2009 with the main aims of
promoting research in the ﬁeld of stem cells, guaranteeing
ethical principles and transferring the results of stem cell
research to clinics, in view of their possible impact on
human health.
The Meeting brought together top Italian scientists to share
their current knowledge and views on the cellular and
molecular aspects of cell death (from programmed cell
deaths, such as apoptosis, anoikis and autophagy, to
necrosis), on the role of programmed cell death in maintaining
an organism’s homeostasis, on the impact of deregulation of
death mechanisms in human diseases, and on the design of
candidate apoptosis targeting therapeutics in Regenerative
Medicine.
The Meeting was also an occasion for stimulating interac-
tions and for the exchange of points of view among senior and
young scientists and undergraduate students.
The Opening Ceremony included the presentation of the
Meeting topics by the President of AICC, Augusto Pessina,
and the President of the Phoenix Foundation, Sergio
Capaccioli, and was followed by the tributes of the local
authorities, that is, Gianfranco Gensini and Sergio Pinzauti,
Deans of the Faculties of Medicine and of Pharmacy
of the University of Florence, respectively, and Antonio Panti,
President of the Order of Physicians of the Province
of Florence.
The Meeting consisted of four main sessions, the synthetic
digests of which are reported below. The details can be found
at http://www1.uniﬁ.it/plrna/index.html.
Apoptosis, Autophagy and Necrosis: Physiology and
Pathology
This session began with the lecture of Angelo Manfredi
(University Vita-Salute San Raffaele, Milan, Italy) on the role of
cell death in the maintenance of tissue homeostasis. Sandra
Zecchi (University of Florence), Francesca Scarlatti (University
of Turin) and Rosanna Supino (Tumour Institute, Milan)
reviewed the main alternative forms of cell death, focusing on
aponecrosis, autophagy and anoikis, respectively. Noteworthily,
aponecrosis, an intermediate form of cell death sharing the
morphologicalandmolecularaspectsofapoptosisandnecrosis,
was shown to abolish any antithesis between these two forms of
cell demise. The physiological roles of cell death within the
response to cellular stresses, such as microgravity, radiation
and electromagnetic ﬁelds, were then examined by Monica
Monici (University of Florence), Aldo Becciolini (University of
Florence) and Lina Ghibelli (University of Tor Vergata, Rome).
Seven young researchers were selected to present their results,
which focused on cellular apoptotic response to the natural
metabolites of lichen (Silvia Caggia, University of Catany), algae
(Gian Luca Sala, University of Modena and Reggio Emilia), and
to the alkaloid voacamine (Stefania Meschini, Superior Institute
of Health, Rome); to the synthetic chemotherapeutics, including
cisplatinum (Barbara Del Bello, University of Siena) and
doxorubicin (Francesco Fabbri, IRST, Forlı ´-Cesena); and to
the immunotherapeutic anti-CD99 monoclonal antibody (Clara
Guerzoni, Rizzoli Orthopaedic Institute, Bologna). The role of
the Ikaros gene in the apoptotic response was discussed by
Daria Capece (University of L’Aquila).
Defective or Excessive Apoptosis in Pathology
The impact of cell death deregulation on a wide variety of
severe human pathologies was discussed. While Gianluigi
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apoptosis in the neurodegenerative diseases, Francesco
Annunziato (University of Florence) focused on the effects
of TGF-b in the development of human Th-17 lymphocytes
and Giorgio Parmiani (University, Hospital San Raffaele,
Milan) described the involvement of T-lymphocyte apoptosis
in the immune response to cancer. The lectures of Davide
Lauro (University of Tor Vergata, Rome) and Carlo Nucci
(University of Tor Vergata, Rome) on the consequences of
excessive apoptosis in diabetes and ophthalmologic pathol-
ogies, respectively, were followed by a discussion on the
relationship between apoptosis and Herpes Simplex virus
(Antonio Mastino, University of Messina) and on the contribu-
tion of apoptosis to the pathogenesis of muscle atrophy and
cachexy (Paola Costelli, University of Turin). Three selected
young researchers discussed the involvement of AMPK and
mll gene in apoptosis (Benedetta Accordi, University of
Padua), the role of NK cells in HIV infection (Domenico
Mavilio, Humanitas Clinical Institute, Milan), and the involve-
ment of lipoic acid in endoplasmic reticulum stress
(Tania Camboni, University of Cagliari).
Modulators of Apoptosis as Therapeutic Tools
Novel paradigmatic modulators of apoptosis as candidate
therapeutic tools were the protagonists of this session. In
particular, the apoptotic effects of the acetyltransferase
inhibitor CPTH6 (Donatella Del Bufalo, National Cancer
Institute ‘Regina Elena’, Rome), the efﬁcacy of the SWCNT
nanoparticles as potential vehicles for antiangiogenetic drugs
(Adriana Albini, Multimedica Group, Milan), the down-
regulators of AKT kinase in reactivation of apoptosis in drug-
resistant cells (Angelo Nicolin, University of Milan), and the
new synthetic molecules in overcoming chemoresistance
(Enrico Mini, University of Florence) were discussed. The
overview of the emerging hypoxic cell targeting CA IX
inhibitors (Claudiu Supuran, University of Florence), imatinib
(Tiziana Negri, Tumour National Institute, Milan), and the
oncosuppressive properties of MET oncogene in the en-
hancement of tumour apoptotic cell death (Maria Flavia Di
Renzo, University of Turin) completed the presentations. The
three selected communications of young researchers
were focused on partenolide (Daniela Carlisi, University of
Palermo), new CXCR4 cycle-peptide inhibitors (Luigi Portella,
CNR, Naples), and ZnO nanoparticles (Maria Condello,
Superior Institute of Health, Rome) as potential anticancer
therapies.
Apoptosis and Regenerative Medicine: Future
Perspectives
This session reﬂected the main purposes of the Phoenix
Stem Cell Foundation for Human Life, which are ‘to promote
translational research in the ﬁeld of stem cell science, to
guarantee the ethical principles and to transfer to clinics the
results of stem cells research, in view of their impact on
human health’. Paolo Di Nardo (University of Tor Vergata,
Rome) introduced the session with a lecture on tissue
engineering as a new perspective in organ repair, which
was followed by Franco Bambi (University of Florence), who
presented an exhaustive analysis of the risks occurring in the
developmentofcellular therapeuticsaccordingtoGMP(Good
Manufacturing Practice, Florence, Italy). Paradigms of stem
cell studies or pivotal application were reported by Maurilio
Sampaolesi(UniversityofPavia),whodiscussedendogenous
and exogenous stem cell administration as antiapoptotic tools
in muscular dystrophies, and by Elisabetta Cerbai (University
of Florence), who described the use of embryonic stem cells
as a model of cardiomyocyte differentiation, as well as by
Benedetta Mazzanti (University of Florence), who presented
studiesofthetherapeuticpotentialofmesenchymalstemcells
in autoimmune diseases. The four selected young research-
ers’ presentations were dedicated to the role of sphingosine
1-phosphate as a differentiation inductor of mesangioblasts
toward smooth muscle cells (Chiara Donati, University of
Florence), the apoptotic role of rexinod in osteosarcoma and
mesenchymal stem cells (Barbara Dozza, Rizzoli Orthopaedic
Institute, Bologna), the bone tissue regenerative capacity of
autologous stromal bone marrow cells in tibia inborn
pseudoarthrosis (Valentina Devescovi, Rizzoli Orthopaedic
Institute) and the potential regenerative role of mesenchymal
stem cells in invertebrate disk degeneration therapy (Elisa
Leonardi, Rizzoli Orthopaedic Institute).
The poster session provided an interesting opportunity
for discussion, especially among young scientists. Particular
curiosity and perplexity were aroused by Marco Ruggiero’s
(University of Florence) ‘HIV and apoptosis of cancer
cells: the killer’s promises’ poster, in which, based on well-
documented literature, he raised the possibility that HIV might
be endowed with anti-tumour activity, which could be
responsible for its symbiotic relationship with humans. Three
prizes for the best posters were awarded to Daria Capece
(University of l’Aquila), for her studies on the characterization
of a novel antiapoptotic Ikaros splice variant, to Clara
Guerzoni (Rizzoli Orthopaedic Institute), for demonstrating
the involvement of the CD99 antigen in apoptosis induction in
Ewing’s sarcoma cells, and to Silvia Zappavigna (Second
University of Naples), for shedding light on the synergic
effects of interferon-beta and troglitazone in the treatment of
pancreatic adenocarcinoma.
The oral presentations were followed by the plenary lecture
of Gerry Melino (University of Tor Vergata, Rome) entitled
‘The determinants of apoptosis as therapeutic targets’, an
interesting overview of cell death mechanisms as targets for
therapeutic drugs, focusing on degradation of P73 as a novel
therapeutic approach to enhance the chemosensitivity of
tumourcells,whichﬁtinperfectlywith thetranslationalspiritof
the Meeting.
Honouring its spirit and commitment to promoting bio-
medical research and supporting outstanding researchers,
AICC awarded four scientists: Monica Marra (Second
University of Naples) and Domenico Mavilio (Humanitas
Clinical Institute, Milan) with the Senior AICC Prize; Elisa
Bianchi (University of Modena and Reggio Emilia) and Lavinia
Nardinocchi (National Cancer Institute ‘Regina Elena’, Rome)
with the Junior AICC Prize.
The Meeting closed with the concluding remarks of Sergio
Capaccioliand Augusto Pessinaand was followed bya visitto
the Renaissance church of San Lorenzo, the ﬁrst cathedral of
Florence, with Costanza Capaccioli, art historian, as guide.
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